sGAG

Blyscan™ sGAG (Glycosaminoglycan) assay kit

Blyscan is an easy-to-use, dye-based assay for quantitative measurement of sulfated glycosaminoglycans (sGAG) & proteoglycans. Suitable samples include cells, tissues and fluids from a wide range of in-vivo and in-vitro sources.

Product Codes

B1000 (110 assays)

B3000 (440 assays, MultiPack)

UK & Ireland orders are supplied direct from Northern Ireland. For other locations please order through our distributor network.

Order through your local distributorUK & Ireland customers: order direct
Recently published research
See the papers ↓

Mammary tissue engineering

Cartilage repair implants

Tumour microenvironment

At a glance

Key Facts

Assay Range
2.5–50 µg/ml
Limit of Detection
2.5 µg/ml
Detection Method
Colorimetric, 656 nm
Endpoint read
Measurements per kit
110
Up to 48 samples in duplicate, plus a standard curve
Sample Types
In-vivo & in-vitro
Cartilage, bone, connective and tumour tissue, urine, synovial and amniotic fluid, cultured ECM
Format
1.5ml Microtubes

The kit

Method

How It Works

1
Prepare the sample

The assay requires that sulfated polysaccharides (sGAGs) are in soluble form. A preliminary enzymatic extraction step is required for solid samples (enzyme not supplied with the kit).

2
Bind the dye

Blyscan Dye Reagent contains DMMB dye in an optimised buffer. Addition of Dye Reagent to samples containing sGAG results in the formation of a dye/sGAG complex, due to a charge interaction between the dye and GAG sulfate groups.

3
Separate and read

Over a 30 minute incubation, dye-labelled sGAGs precipitate out of solution and are collected by centrifugation. Following removal of unbound dye, the remaining bound dye is released from the complex by addition of dye dissociation reagent. Released dye is measured spectrophotometrically at 656nm.

4
Quantify

The sGAG content of unknown samples may be quantified by comparison against a calibration curve prepared using a standard of purified Chondroitin-4-sulfate supplied with the kit.

Suitable samples

In-vivo: Solid samples, including cartilage, bone, connective tissue, tumour tissue

In-vivo: Liquid samples, including fluids such as urine, amniotic or synovial fluid.  

In-vitro: Solid samples, such as deposited ECM on 2D/3D culture surfaces, by enzymatic treatment

In-vivo: Liquid samples, Culture media during 2D/3D cell culture.

The assay requires that sulfated polysaccharides or sGAGs are in a soluble form. A preliminary enzymatic extraction step is required for solid samples (enzyme not supplied with kit).

The assay is not suitable for use with samples containing alginates or that comprise degraded sulfated disaccharide fragments.

Before you start

This kit is designed for research use only. Not for use in diagnostic procedures.
Kit requires access to a centrifuge, as well as a spectrophotometer/colorimeter capable of absorbance detection at 656nm.
Specific sample preparation protocols may require customer to provide further reagents, consult assay manual for further information.

Background

About this assay

What's in the kit

Blyscan sGAG kit contents:‍

1. Blyscan Dye Reagent (1x110ml)

2. sGAG Reference Standard (1x5ml, 100µg/ml Bovine tracheal chondroitin 4-sulfate)

3. Dissociation Reagent (1x110ml)

4. Sodium Nitrite (1x15ml)

5. Acetic Acid (1x15ml)

6. Ammonium Sulfamate (1x15ml)

7. 1.5ml micro-centrifuge tubes for dye-labelling reaction.

8. Assay kit manual

NB: Additional reagents may be required for sample preparation prior to assay. Consult manual or contact us for further details.

Background

Understanding Glycosaminoglycans (GAGs) and Proteoglycans

Glycosaminoglycans (GAGs) are members of the polysaccharide family that play a crucial role in various biological processes. They consist of repeated disaccharide units, typically of hexosamine, (N-acetylated or N-sulfated), paired with uronic acid (GlcA or IdoA) or galactose. Many GAGs have an overall ‘negative charge’ due to the addition of sulfate groups. This charge influences cell and extracellular matrix interactions.

 Common examples of GAGs include Chondroitin Sulfate, Dermatan Sulfate, Heparin, Heparan Sulfate, and Keratan Sulfate.

 NB: Since Hyaluronic Acid is a non-sulfated GAG it cannot be detected by the Blyscan assay. If you need to measure hyaluronic acid, we recommend using our ‘Purple-Jelley’ Hyaluronic acid measurement kit!

‍

The Role of Glycosaminoglycans in Tissues

GAGs and proteoglycans have essential functions in tissues and organisms including acting as a scaffold to provide biophysical support, and maintaining cartilage hydration. They also play a vital role in biochemical processes such as cell adhesion and signalling.

‍

‍What is the origin of the Blyscan assay name?

Blyscan is an Old English word meaning ‘to shine’ and from which the word ‘blush’, (blushing), may have been derived. This was an appropriate choice as the Blyscan Assay contains a blue dye which 'blushes' bright pink when it binds to sulphated glycosaminoglycans!

How the dye-binding chemistry works

How does the Blyscan assay work?

Blyscan dye reagent contains DMMB dye in an optimised buffer. Addition of Dye reagent to samples containing sGAG results in the formation of a specific dye/sGAG complex due to a charge interaction between dye and GAG sulfate groups.

* Unlike some older dye-based kits, the Blyscan Dye reagent has been formulated to minimise binding to other charged sample components such as nucleic acids.

‍

Support

Frequently asked questions

The questions our technical team is asked most about this kit. Not answered here?

Ask us directly

What is the sensitivity of the Blyscan assay?

0.25μg/100μl, equivalent to 2.5μg/ml

How long does the Blyscan assay take to run?

1 hour

Can I differentiate between N-sulfated and O-sulfated glycosaminoglycans?

Yes. The kit includes reagents to separate N-sulfated GAGs (heparin and heparan sulfate) from O-sulfated GAGs (such as chondroitin, dermatan and keratan sulfates).

Sodium nitrite and acetic acid are supplied with the kit. These form nitrous acid, which cleaves the GAG chain at N-sulfated glucosamine residues, removing the dye-reactive sulfate groups. After treatment, Blyscan therefore measures only the O-sulfated GAG.

The method requires a heparin or heparan sulfate standard (not included with the kit). This is used in combination with the assay standard to prepare a comparative calibration curve (comprising known mixtures of purified N- and O-sulfated GAGs).

In outline:

  1. Mix 100 µl of sample with 100 µl of sodium nitrite and 100 µl of acetic acid.
  2. Leave for 60 minutes at room temperature.
  3. Add 100 µl of ammonium sulfamate to remove excess nitrous acid. Expect some bubbling.
  4. Mix for 10 minutes, then assay 100 µl of the mixture as normal.

The results are calculated as follows:

  • O-sulfated GAG is the result for the treated sample, allowing for the four-fold dilution.
  • N-sulfated GAG is total sGAG (the untreated sample) minus O-sulfated GAG.

What absorbance values can samples be measured at?

The absorbance peak for Blyscan dye in the dissociation reagent is 656nm. This absorbance is suitable for use with most colorimeters and microplate readers with a red filter.

How do I prepare samples for measurement with the Blyscan assay?

Blyscan measures sulfated glycosaminoglycans (sGAG) in solution. Clear liquids can usually be assayed directly. Tissues and cell layers first need an enzyme digest to release their sGAG in a soluble form.

  • Clear liquids (culture medium, urine, synovial fluid): remove any cloudiness or particles by centrifugation, then assay.
  • Synovial fluid: viscous samples can be diluted in PBS for accurate pipetting. The hyaluronan in synovial fluid doesn't interfere.
  • Urine: an early-morning sample is best. Assay two volumes (25 µl and 100 µl) and express results per mmol of creatinine or per 100 ml.
  • Tissues, cartilage and bone: digest 20–50 mg of tissue in 1 ml of papain extraction reagent at 65 °C. Soft tissue takes about 3 hours; cartilage and bone need overnight. Centrifuge at 10,000 x g for 10 minutes and assay the supernatant.
  • Cell cultures: collect the medium, then digest the cell layer in papain reagent at 65 °C for 3 hours. Total sGAG is the medium and the digest added together. The manual also describes how to measure the cell-surface, matrix and cell-content fractions separately.

Papain isn't supplied in the kit as the active enzyme isn't stable in transit. See the papain questions below for where to purchase it and how to prepare the papain extraction buffer.

If samples contain a lot of salt or detergent, prepare the standard curve in the same diluent. For low or variable samples, the Blyscan sGAG Isolation & Concentration Pack (B1015) can be used. Contact us for further information.

Full protocols are in the Blyscan manual. You can download it from the Documentation links at the top of this page.

Why is papain used for sample extraction, and where can I get it?

Sulfated GAGs (sGAG) must be in soluble form for Blyscan analysis. A convenient means to release them from solid samples is digestion with papain. Active papain isn't stable in transit, so we can't ship it with the kit. It is generally purchased in an inactive form and activated by diluting it into a phosphate buffer containing cysteine and EDTA (see the next question for how to prepare it).

Recommended enzyme:

We recommend customers purchase ‘Papain from papaya latex’ (product code P3125) from Merck:

https://www.sigmaaldrich.com/GB/en/product/sigma/p3125

A suitable alternative would also be the Papain suspension (product code PAP) by Worthington Biochemical:

http://www.worthington-biochem.com/pap/cat.html

I have the papain enzyme, how do I prepare the Papain sample extraction buffer?

Papain is supplied as an inactive suspension. It only becomes active once it's diluted into a phosphate buffer containing cysteine, which activates the enzyme, and EDTA. Make up the papain extraction reagent as follows:

  1. Prepare 50 ml of 0.2 M sodium phosphate buffer, pH 6.4. This phosphate buffer guide may help.
  2. Add 400 mg sodium acetate.
  3. Add 200 mg EDTA, disodium salt.
  4. Add 40 mg cysteine HCl.
  5. Stir until everything has dissolved.
  6. Add papain suspension to give about 5 mg of active enzyme. With Merck P3125 this is typically around 250 µl. The enzyme concentration varies from batch to batch, so check the datasheet supplied with your enzyme and calculate the volume you need.
  7. Stir to mix.

The reagent keeps for up to 7 days at 4 °C. Use it at 65 °C as described in the sample preparation question above.

Can the assay be used on urine, synovial fluid or other water-based samples?

Yes. Clear, water-based samples such as urine and synovial fluid can usually be assayed directly, without an enzyme digest.

  • Cloudy samples: remove any cloudiness or particles first by centrifugation.
  • Synovial fluid: dilute viscous samples in PBS so they can be pipetted accurately. Hyaluronan doesn't interfere with the assay.
  • Urine: an early-morning sample is best. Assay two volumes (25 µl made up to 100 µl with water, and 100 µl undiluted). Urinary sGAG levels vary widely, so this makes it more likely that one reading falls within the standard curve. If both give the same result once you allow for the dilution, you can also be confident the urine isn't interfering with the assay. Express results per mmol of creatinine or per 100 ml.
  • High salt or detergent: if samples contain either, prepare the standard curve in the same diluent.

Since these samples often vary in concentration and composition, we have developed the Blyscan sGAG Isolation & Concentration Pack (B1015, 100 samples), which can help with sample preparation. Contact us for details.

How can I prevent dye-labelled glycosaminoglycan pellets falling or sliding out of the tube when I am removing the unbound dye?

This can be minimised by modifying the previous centrifugation step as follows: First perform the usual spin at 13000 x g for 10 minutes. Then allow the centrifuge to stop. Wait for 2 – 3 minutes then proceed with a second 13000 x g centrifugation for a further 5 minutes. This should improve the adhesion of the dye-labelled glycosaminoglycan containing pellets to the tubes.

In the literature

How researchers use Blyscan

Used as an sGAG readout in cartilage tissue engineering, and a key assay in decellularisation and MPS research.

Cartilage & disc engineering

sGAG made by chondrocytes and stem cells.

Decellularised tissue QC

sGAG retained after processing.

MPS & gene therapy

Tissue and urinary GAGs as therapy readouts.

Tumour & tissue biology

Sulfation and GAG in disease tissue.

Typical samples

Engineered cartilage · cell pellets & hydrogels · culture medium · decellularised tissue · urine · tumour tissue

Selected papers

A curated selection of peer-reviewed work using this kit, chosen to span different tissues, models and questions.

Volumetric printed biomimetic scaffolds support in vitro lactation of human milk-derived mammary epithelial cells

Sulfated GAG in decellularised mammary tissue. Blyscan was used on decellularised mammary tissue, alongside collagen, elastin and DNA assays, to characterise the native matrix in a study of volumetric-printed scaffolds that support in vitro lactation.

·
Science Advances
·
·
DOI

Anti-swelling and self-activating artificial proteoglycan assemblies as cartilaginous implant for post-microfracture healing

GAG in stem cells on artificial-proteoglycan assemblies. Blyscan was used on papain digests at 65 °C overnight, normalised to DNA, to compare GAG production by bone marrow stem cells after 21 days of chondrogenic induction on different proteoglycan assemblies.

·
Nature Communications
·
·
DOI

Extracellular Matrix Sulfation in the Tumor Microenvironment Stimulates Cancer Stemness and Invasiveness

Sulfated GAG in human lung adenocarcinoma tissue. Blyscan was used on patient-derived lung adenocarcinoma and matched normal lung tissue, showing tumours were enriched in sulfated GAGs and supporting the study's link between matrix sulfation and cancer stemness.

·
Advanced Science
·
·
DOI

Engineering memory T cells as a platform for long-term enzyme replacement therapy in lysosomal storage disorders

Tissue and urinary GAG in an MPS I mouse model. Blyscan was used on lysates from eight organs, digested overnight at 55 °C with proteinase K, DNase and RNase, and on urine, to measure GAG reduction as the efficacy readout for engineered memory T cells delivering IDUA.

·
Molecular Therapy
·
·
DOI

Collagen hydrogel viscoelasticity regulates MSC chondrogenesis in a ROCK-dependent manner

sGAG in MSC-laden collagen hydrogels. Blyscan was used on freeze-dried hydrogel constructs digested with papain at 65 °C for 12 hours, with DNA measured alongside, showing faster-relaxing collagen hydrogels supported more sGAG deposition over 21 days of MSC chondrogenesis.

·
Science Advances
·
·
DOI

Fluoxetine ameliorates mucopolysaccharidosis type IIIA

GAG storage in liver and brain of MPS IIIA mice. Blyscan was used on liver and brain digested in papain extraction reagent for 3 h at 65 °C, normalised to DNA and read at 656 nm, to show that fluoxetine reduced GAG storage.

·
Molecular Therapy
·
·
DOI

Next steps

Not sure which kit, or ready to order?

Tell us your sample type and what you want to measure, and we will point you to the right kit. Biocolor kits are sold through local distributors worldwide, and direct to customers within the UK and Ireland.

Talk to us

Our Belfast-based team answers technical and sales questions.

Contact us →

Where to buy

Find your local distributor, or order direct in the UK and Ireland.

Find your distributor →